TY - JOUR
T1 - How safe is safer sex? High levels of HSV-1 and HSV-2 in female sex workers in London
AU - Fox, Julie
AU - Taylor, G. P.
AU - Day, S.
AU - Parry, John
AU - Ward, H.
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2006/10
Y1 - 2006/10
N2 - Female sex workers in Europe have low levels of sexually transmitted infections, attributable to condom use. The aim of this paper is to describe the seroepidemiology of HSV-1 and HSV-2 in female sex workers in London by using a 15-year prospective study of 453 sex workers. The seroprevalence of HSV-1 was 74·4% and independently associated with birth in a 'transitional country' (OR 5·4, 95% CI 1·61-18·20). The seroprevalence of HSV-2 was 60% and declined over time; it was also independently associated with time in sex work (OR 2·12, 95% CI 1·23-3·65) and birth in a 'developing country' (OR 2·95, 95% CI 1·34-6·48). We show that a cohort of sex workers with extensive condom use and little known sexually transmitted infection have high levels of HSV-1 and HSV-2 infection, suggesting that condoms may not be universally protective. Sex workers are candidates for HSV vaccine efficacy or intervention studies.
AB - Female sex workers in Europe have low levels of sexually transmitted infections, attributable to condom use. The aim of this paper is to describe the seroepidemiology of HSV-1 and HSV-2 in female sex workers in London by using a 15-year prospective study of 453 sex workers. The seroprevalence of HSV-1 was 74·4% and independently associated with birth in a 'transitional country' (OR 5·4, 95% CI 1·61-18·20). The seroprevalence of HSV-2 was 60% and declined over time; it was also independently associated with time in sex work (OR 2·12, 95% CI 1·23-3·65) and birth in a 'developing country' (OR 2·95, 95% CI 1·34-6·48). We show that a cohort of sex workers with extensive condom use and little known sexually transmitted infection have high levels of HSV-1 and HSV-2 infection, suggesting that condoms may not be universally protective. Sex workers are candidates for HSV vaccine efficacy or intervention studies.
UR - http://www.scopus.com/inward/record.url?scp=33748349038&partnerID=8YFLogxK
U2 - 10.1017/S0950268806006133
DO - 10.1017/S0950268806006133
M3 - Article
C2 - 16569273
AN - SCOPUS:33748349038
SN - 0950-2688
VL - 134
SP - 1114
EP - 1119
JO - Epidemiology and Infection
JF - Epidemiology and Infection
IS - 5
ER -